BioTech
AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality
Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing. To
Casey Ross and Matthew Herper
May 20, 2024